Related Experiment Video
Updated: Jul 15, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Novel Tetrahydroquinazoline Derivatives for Treating HIV Infection or AIDS or AIDS Related Complex
1Arclin USA LLC, 1150 Sanctuary Parkway, Suite 100, Alpharetta, Georgia 30009, United States.
Novel tetrahydroquinazoline derivatives offer a new approach to treating Human Immunodeficiency Virus (HIV) infection, Acquired Immunodeficiency Syndrome (AIDS), and AIDS-Related Complex (ARC). These compounds and their preparation methods are detailed for therapeutic applications.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Virology
Background:
- Human Immunodeficiency Virus (HIV) infection remains a significant global health challenge.
- Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex (ARC) represent advanced stages of HIV infection.
- Development of novel therapeutic agents is crucial for combating HIV/AIDS.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Sexually Transmitted Infections
Cryptococcal Meningitis

